Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Haplotyping and DCA PK in Healthy Volunteers
NCT02690285Phase 1Completed
- Sponsor
- University of Florida
- Start
- Mar 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dichloroacetate in Pyruvate dehydrogenase complex deficiency (PDCD) (2 arms), sponsored by University of Florida. Primary endpoint: GSTZ1 haplotype frequency. Started Mar 2016; status: completed.
02
Drugs
dichloroacetate
03
Conditions
Pyruvate dehydrogenase complex deficiency (PDCD)
Beyond the preview
Go deeper on NCT02690285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02690285.